Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106927

Metabolism of plasminogen in healthy subjects: effect of tranexamic acid

D. Collen, G. Tytgat, H. Claeys, M. Verstraete, and P. Wallén

Laboratory of Blood Coagulation, Department of Medicine, University of Leuven, Leuven, Belgium

Department of Medical Chemistry, Umeå University, Umeå, Sweden

Find articles by Collen, D. in: PubMed | Google Scholar

Laboratory of Blood Coagulation, Department of Medicine, University of Leuven, Leuven, Belgium

Department of Medical Chemistry, Umeå University, Umeå, Sweden

Find articles by Tytgat, G. in: PubMed | Google Scholar

Laboratory of Blood Coagulation, Department of Medicine, University of Leuven, Leuven, Belgium

Department of Medical Chemistry, Umeå University, Umeå, Sweden

Find articles by Claeys, H. in: PubMed | Google Scholar

Laboratory of Blood Coagulation, Department of Medicine, University of Leuven, Leuven, Belgium

Department of Medical Chemistry, Umeå University, Umeå, Sweden

Find articles by Verstraete, M. in: PubMed | Google Scholar

Laboratory of Blood Coagulation, Department of Medicine, University of Leuven, Leuven, Belgium

Department of Medical Chemistry, Umeå University, Umeå, Sweden

Find articles by Wallén, P. in: PubMed | Google Scholar

Published June 1, 1972 - More info

Published in Volume 51, Issue 6 on June 1, 1972
J Clin Invest. 1972;51(6):1310–1318. https://doi.org/10.1172/JCI106927.
© 1972 The American Society for Clinical Investigation
Published June 1, 1972 - Version history
View PDF
Abstract

The metabolism of human plasminogen labeled with radioactive iodine was studied in 12 healthy men. The labeled plasminogen had a high specific activity and the same elution on Sephadex G-100 as the plasminogen activity in plasma. Immunoelectrophoresis revealed a single precipitin line. Polyacrylamide gel electrophoresis revealed six main bands, all with plasminogen properties and radioactivity. The purified plasminogen behaved as a homogeneous protein in the turnover experiments. The plasma radioactivity data were adequately approximated by a sum of two exponential terms. The metabolism of plasminogen was therefore represented by a two-compartment mammillary model.

Results in the 12 normal subjects were as follows: plasma plasminogen concentration 20.8±1.9 mg/100 ml; intravascular plasminogen pool 0.66±0.14 g; intravascular fraction 0.59±0.06; fractional catabolic rate 0.55±0.09 of the plasma pool per day; half-life of the plasma radioactivity 2.21±0.29 days. Circulating large-molecular-weight degradation products of labeled plasminogen could not be detected by Sephadex G-100 gel filtration.

The plasminogen turnover rate was normal in a patient with Behçet's syndrome and low circulating plasminogen activator activity. This finding supports the concept that under normal conditions the primary pathway of plasminogen catabolism is not via the formation of plasmin.

The in vivo effect of tranexamic acid, a potent inhibitor of plasminogen activation, on the turnover of labeled plasminogen was studied in five normal subjects. When 1 g was administered perorally t.i.d. to three of them, one showed an increased plasminogen turnover. A 2 g dose administered t.i.d. to the other two caused markedly increased catabolism in both. This increase may be attributable to a direct reversible effect of tranexamic acid on the plasminogen molecule.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1310
page 1310
icon of scanned page 1311
page 1311
icon of scanned page 1312
page 1312
icon of scanned page 1313
page 1313
icon of scanned page 1314
page 1314
icon of scanned page 1315
page 1315
icon of scanned page 1316
page 1316
icon of scanned page 1317
page 1317
icon of scanned page 1318
page 1318
Version history
  • Version 1 (June 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts